Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092960 · ClinicalTrials.gov registry record · NA
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
A NA study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- NA
- Development phase
- 424
- Enrollment target
NCT03092960: Completed NA study, sponsored by Palo Alto Medical Foundation.
NCT03092960 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 424 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03092960, a NA study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 424 participants
- Enrollment target
Study Summary
The purpose of this study is to test a flexible lifestyle program designed to help Latino men make healthy lifestyle changes to lower their risk of developing diabetes and heart disease. The program is called HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas; English translation: Men with choices to improve well being and decrease chronic disease risk).
Primary Outcome
Number and Percentage of men who achieve 5% or more of weight loss compared to their baseline weight
Interventions
- BEHAVIORAL Minimal intensity intervention
- BEHAVIORAL HOMBRE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
What the finished NCT03092960 record still lists
NCT03092960 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Minimal intensity intervention is the first listed.
NCT03092960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03092960 about?
NCT03092960 is a clinical study titled "The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men". The purpose of this study is to test a flexible lifestyle program designed to help Latino men make healthy lifestyle changes to lower their risk of developing diabetes and heart disease. The program is called HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades cr...
What is the current status of trial NCT03092960?
This trial is currently completed. It is a NA study. The enrollment target is 424 participants. The study started on 2017-04-03. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03092960?
The interventions under investigation include: Minimal intensity intervention (BEHAVIORAL), HOMBRE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092960?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03092960's enrollment target sits among peer trials
424 238th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI